Eosinophilic granulomatosis with polyangiitis (egpa) - One-year follow-up study using mepolizumab anti-il5 therapy as a steroid sparing therapeutic approach

Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2020
This article has no abstract
Epistemonikos ID: 61181d01c4b5bae595f9072f717233e0ef461ddb
First added on: Feb 12, 2025